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Abstract
This study aimed to confirm the presence of Blocking Factors (BFs) in Mixed Lymphocyte Cul-
ture (MLC) from female normal reproducer and sub-fertile rabbit inoculated with two injection 
of the allogenic lymphotherapy (LIT) to analyze its effect on rate fertility and pregnancy success. 
The BFs measuring was done intervening MLC with MTT-Formazan non-radioactive technique. 
It was demonstrated BFs presence in MLC in female rabbit groups.. In sub-fertile female repro-
ducers treated with allogenic lymphotherapy a significant increase in the level of FBs after every 
LIT was observed, as well as a rate fertility increase.. Furthermore, it was established that BFs act 
on cell proliferation inhibiting the MLC of other species, clearly indicating that the inhibit effect 
of the BFs is inter-specific and no intraspecific as had sustain until now. 
Key words: lymphotherapy, blocking factors, mixed lymphocytes culture, subfertiles females rab-
bit and fetal allograft.
La Linfoterapia induce aumento de factores bloqueadores 
y corrige problemas de infertilidad.
Resumen
Esta investigación se basó en un modelo experimental de origen animal, dirigido a comprobar 
la existencia de factores bloqueadores (FBs) del cultivo mixto de linfocitos (CML) en grupos de 
conejas reproductoras normales y subfértiles. A los animales de experimentación se les aplicó dos 
dosis de Linfoterapia (LIT) alogénica, con el fin de analizar sus efectos en el aumento de la tasa de 
fertilidad y del éxito gestacional. La medición de los FBs se realizó mediante CML con la técnica 
no radioactiva MTT-Formazan. Se comprobó la existencia de FBs del CML en todos los grupos 
de conejas estudiados. En conejas reproductoras subfértiles tratadas con LIT alogénica se observó 
un incremento significativo de los niveles de los FBs después de cada LIT, así como el aumento 
en la tasa de fertilidad de las mismas. Además, se estableció que los FBs de proliferación celular 
actúan inhibiendo el CML de otras especies, lo que indica claramente que el efecto inhibitorio de 
FBs es interespecífico y no intraespecífico como se ha sostenido hasta ahora.
Palabras clave: Linfoterapia, factores bloqueadores, cultivo mixto de linfocitos, Oryctolagus cu-
niculus, aloinjerto fetal.
Introduction
In 1994 Beer and Billingham established the bases 
of the immunology of reproduction. These initial 
studies demonstrated that the uterus is not a im-
munology privileged tissue. Furthermore, they pos-
tulated different theories to explain the survival of 
fetal allograft during the pregnancy and established 
the immunotherapy as treatment to recurrent spon-
taneous miscarriage (1). Subsequent studies develo-
ped on animal models allowed to understand the 
mechanism responsible of the fetal reabsorptions or 
habitual aborts in addition to the alloinmunothera-
py effects in the reproduction (2, 3).
It is currently accepted that the mothers recogni-
ze immunologically to her allogenic embryo and 
respond strongly to the blastocyst implantation in 
endometrium. For this reason has been thought 
that there are factors that regulate or suppress the 
immunological response against the embryo in 
development, allowing to success of the placental 
mammals from mammals perspective (4).
One of main purposes of immunology of repro-
duction is establish experimental animals models 
to investigate the phenomenon of the response 
immune maternal against the fetal allograft. The 
reproductive efficiency of species for commercial 
utilization in livestock field have been significantly 
affected for bad practices of the genetic improve-
ment programs that lead to high levels of endo-
gamy. This has generated a very low fertility rate 
threatening the rusticity of the others species. The 
importance of this study is to evaluate the effect 
of the immunotherapy as treatment for correcting 
specific problems of fertility.
Blocking Factors (BFs). Molecules that prevent im-
mune rejection of the fetal allograft during preg-
nancy (5,6).
Lymphoteraphy (LIT) or Immunotheraphy. Ppurified 
preparation of leukocytes that is administered intra-
dermic. Approximately 50 million cells are inocula-
ted from the father or someone related to him (4).
Fetal Allograft: It has been considered that fetus is 
a semi allograft due that possess 50 % of genetic 
information derivate from the father. It could ex-
press antigens from the father or its owns, which 
would be susceptible to immune recognition and 
rejection (3).
Subfertile Females. It have been consider subfer-
tile females those rabbit repeat services, meaning 
being mount often and not stay pregnant. The 
cause of the subfertility can aggravate immunne 
problems for the high level endogamics. 
Materials and methods
Control group and problem group for the study. 
BFs in serum were quantifying from 55 female 
rabbits. Treatment group consisted of 9 subferti-
le reproducer rabbits inoculated twice with LIT. 
8 subfertile reproducer rabbits injected twice 
with sterile saline solution (SSS) denominated 
control group;. 20 nulliparous rabbits (80 days) 
10 normal multiparous rabbits and 8 post-partu-
rition normal multiparous were included. Males 
which have been verified its fertility and were 
in active condition during time the study were 
utilized as reproducers . Mononuclear cells were 
obtaining by puncture intracardiac using a steri-
le heparinized syringe from New Zealand white 
(NZW) rabbits that were going to be sacrificed. 
Serums from females problem and control were 
drawn blood obtaining from for vein marginal 
puncture of the ear into pediatrics Vacutainer 
tube additive-free. 
Protocol for setting up of the MLC, with the tech-
nical non-radioactive MTT-FORMAZAN. Non-
Radioactive cell proliferation assay is a colorime-
tric method to determine the viable cells number 
in culture. In this assay a tetrazolium compound 
(3-4,5-dimetyl thiazol-2-hl)-2,5 difenil tetrazo-
lium brinide) MTT is bio-reduced by cells to For-
mazan that is soluble in culture medium inside 
of the mitochondria. The conversion is done by 
dehydrogenase enzymes found at the matrix mito-
chondrial in metabolically active cells (7-9).
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The lymphocytes were separated from whole blood 
by Ficoll-Hypaque gradients (density 1,077) and 
centrifuge to 3000 m.p.r. for 40 minutes. With a 
Pasteur sterile pipette, the buffy layer was carefu-
lly removed and transferred to another tube and 
10 ml RPMI-1640 medium were add, centrifuged 
for 10 minutes (2000 rpm) this procedure were 
done twice.. The male cells or inducers were treat 
with Mitomycin C 0,25 mg/ml (for every one ml 
cells is utilize 0,1 ml of Mitomycin C) during 20 
minutes at 37ºC. The cells were adjust to a final 
concentration of 2 x 106 cells/ml with RPMI-1640 
medium adjusting the counts in Neubauer cham-
ber and the viability using trypan blue in micros-
copy 40x.
Preparation of Assay Plates. 30 µl of serum from 
females rabbits to be tested were added to 100 µl 
of RPMI-1640 by triplicate. 50µl of responds cells 
(5000 cells/µl) and 50 µl (5000 cells/µl) induces 
cells previously inactive with Mitomycin C were 
added in to each well depending upon the num-
bers of test. The plate was incubated at 37ºC for 
72 hours in a humidified 5% CO2 atmosphere. 
Absorbance measure and data recording. 15 µl of the 
dye solution were added to each well and the plate 
was incubated at 37ºC for 4 hours in humidified 
5% CO2 atmosphere. After 4 hour 100 µl of the 
Solubilization/Stop Solution was add to each well.
Interpretation of Results. The assay plate was read 
using an ELISA plate reader Anthos 2001 (540 
nm and 620 nm filter reference) the inhibitory 
effect (IE) was calculated according to this formula.
Abs. CML. Test serum 
IE = 1-   x 100
Abs. CML. Test serum AB+
Results
BFs levels from each rabbit were measured before 
and after treatment, described table 1 and 2. The 
proliferative response in presence of serums (from 
female under study) was assessed in the MLC.
Table 1. BFs results from sub-fertile problem females without 
and with dose of the lymphotherapy.
Without LIT 1 LIT 2 LIT 3 LIT 
A B C D
      1 %      30% 50,95%
22,08% 32,77% 47,72%   59,1%*
21,76% 38,64% 47,08% 52,93%*
35,72% 42,21% 56,17% 55,85%*
34,10% 43,51% 48,06%
24,03% 48,71% 57,80%
21,11% 54,23% 60,39%
10,12% 22,07% 29,9%
  6,55% 36,66% 41,64%
Table 2. BFs results from sub-fertile problem females without 
and with dose of sterile salt solution.
Without SSS 1 dose de SSS 2 Dose SSS 
A B C
23,96% 21,76% 29,50%
31,14% 29,23% 33,65%
22,16% 22,73% 25,35%
23,36% 21,43% 26,27%
24,56% 25,98% 27,19%
20,56% 19,81% 21,66%
19,36% 18,51% 17,06%
20,84% 23,38% 19,82%
BFs results from control females rabbit were obtai-
ned, mean 28,69 %, value considered as reference 
for normal reproducer females without allogenic 
Lymphotherapy treatment. For sub-fertile repro-
ducer females the BFs mean was 20,79% without 
alloimmunotherapy inoculation. BFs value of 
38,25% were found after first alloinmunization of 
sub-fertile reproducer females, after the second lym-
photherapy dosage the BFs value were 48,17% and 
with third dosage the values average were 55,90%. 
These results indicate a significant increase of the 
BFs directly proportional to the number of lym-
photherapy dosage. Furthermore the lymphothe-
rapy increased the efficiency reproductive level, in 
other words success pregnancy. Table 3 and 4.
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Table 3. Reproductive efficiency of females with lymphotherapy 
Problems Females (LIT)
No Condition No dose Covers
1 Pregnant 2 LIT 1
2 Pregnant 3 LIT 2
3 Pregnant 3 LIT 2
4 Pregnant 3 LIT 2
5 Pregnant 2 LIT 1
6 Pregnant 2 LIT 1
7 Pregnant 2 LIT 1
8 Pregnant 2 LIT 1
9 Pregnant 2 LIT 1
Table 4. Reproductive efficiency of females with SSS treatment
Females control (SSS)
No Condition No dose Covers
1 Failure 2 SSS 4
2 Pregnant 2 SSS 1
3 Pregnant 2 SSS 1
4 Failure 2 SSS 4
5 Failure 2 SSS 4
6 Pregnant 2 SSS 1
7 Failure 2 SSS 4
8 Failure 2 SSS 4
The average BFs for nulliparous females (80 days) 
was 17.2%, normal multiparous, 30.06% and 
post-parturition multiparous 44.94%. 
It was assessed the effect of each treatment in the 
number and condition of litter. Were obtained as 
many females treatment with LIT as the females 
treatment with SSS, Table 5.
Table 5. Measure of treatments effect in the number and condi-
tion of the litter reproducer females with treatment (LIT and SSS)
Numbers young 
the Females 
treatment with LIT
Numbers young 
the Females 
treatment with SSS
1a  
Paarturition
2a  
Parturition
1a  
Parturition
2a  
Parturition
10 8 - -
7 8 6 4
8 8 6 10
10 8 - -
12 10 - -
2 11 9 8
8 10 - -
7 9 - -
4 11
Finally serums from 8 females of different species 
were tested in human MLC to assess proliferative 
response. All the samples tested inhibited the po-
sitive reaction of MLC. Table 6
Table 6. BFs results for serums proliferative respond from fema-
les in the MLC in different species with same cell source. 
Females pregnant Females non-pregnant
Animal BFs Animal BFs
Cow 1 37,33% Goat 28,87%
Cow 2 26,73% Rabbit 2 22,07%
Cow 3 31,80% Agouti paca 2 26,81%
Agouti paca 1 35,27%
Rabbit 1 40,23%
Statistical Analysis
ANOVA analysis (randomized complete block 
design) were used to evaluate the effect of lym-
photherapy in the increasing of BFs in sub-fertile 
reproducers females compare with sub-fertile fe-
males group treated with salt solution. (10,11).
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Using the ANOVA results significance or the ave-
rage-to-average method comparisons were carried 
out applying Tukey’s multiple comparison tests (11).
Statistically significant differences were found for 
the group treated with lymphotherapy and highly 
significant between the moment without lym-
photherapy and after second lymphotherapy dosa-
ge, Table 7 and graphic 1.
Table 7. ANOVA I Treatment with LIT
Source 
of variation LG SC CM
F 
Calculate
(h-1) Block 8 1872,33 234,04 5,41
(t-1)Treatment 2 3972,50 1986,25 45,89
(h-1) (t-1) Error 16 692,41 43,27
Graphic 1. Comparison among the LIT treatment means 
There were no statistically significant differences 
in outcome for treatment group with SSS, therefo-
re all treatment have the same effect, Table 8 and 
Graphic 2.
Table 8. ANOVA II treatment with SSS.
Source 
of variation LG SC CM
F 
Calculate
(h-1) Blocks 7 326,85 46,7 14,62
(t-1) Treatments 2 22,25 11,13 3,52
(h-1) (t-1) Error 14 44,32 3,17
Graphic 2. Comparison SSS treatments means 
Discussion
Due to the different theories proposed to explain 
the fetal allograft survival various research groups 
had been focus their effort in study in depth the 
main role of BFs in preventing the immune re-
jection of the mother against fetus. For this rea-
son the BFs in sub-fertile reproducer rabbit were 
studied. The main goal was quantify the BFs of 
the MLC in animal models which could bring 
out new information that could being applied in 
human reproduction especially in reproductive 
problems with immunologic origin that cause fre-
quent miscarriages. 
In this study the lymphotherapy effect in the in-
creasing BFs levels was studied and consequently 
the greatest pregnancy success chance in compari-
son with the SSS treatment group in t sub-fertile 
reproducer rabbits. 
The results showed that there is a concentration 
increase of BFs from MLC after each lymphocytes 
injection in sub-fertile females. That supports the 
initial hypothesis since differences highly signi-
ficant were find between females without lym-
photherapy and females after second injection 
of lymphotherapy (p>0.01). In contrast there not 
found differences among females treated with SSS 
(p<0.05). Which indicate that the lymphotherapy 
is useful for increasing the BFs levels and conse-
quently correct specific cases of infertility being 
an extremely useful immune therapy in case of 
recurrent miscarriages in human(12-14) or other 
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mammals. Furthermore, none harmful effect of 
the lymphotherapy were observed in that spe-
cies. Contrary to other studies that sustain that 
lymphotherapy is not treatment that improve the 
pregnancy success in women with recurrent mis-
carriages. These results could be were linked to 
psychology hormones mediated effect (12,13). 
The rate fertility success observed  in sub-fertile 
females treated with LIT was greater than the rate 
in females treated with SSS. The incidence of the 
LIT was clear since 66% of the females got preg-
nant at the second LIT injection and the outco-
me were the 100% at the third injection. The 
BFs levels were optimal at the third LIT injection 
where highly significant differences (p>0.01) were 
observed between females without LIT and fema-
les that received up to three LIT injections. Mo-
reover, it was showed that the pregnancy efficiency 
was closely tied to good level of BFs.
The litter size depended of a lot external variables 
such as diet, stress, genetic of the animal and the 
weaning which is related with the handing of pro-
duction (13). The variability of the young rabbit’s 
number went from 1 at 20 per litter being a very 
random data to take into account as reference of 
treatment with lymphotherapy. Furthermore, note 
that prenatal mortality occurs usually in all mul-
tiparous species of mammals, such as rabbits, it 
seems that when there is an excessive number of 
morulas the normal uterine nutrients supply is 
insufficient for the survival and can induce death 
of considerably number of embryos, phenomenon 
called fetal reabsorption (14-18). Base on the abo-
ve and the study results the lymphotherapy was 
associated with the fetal reabsorptions decrease 
which could indicate that lymphotherapy could 
prevent the selection of consanguineous embryos.
at tuterus level 
The quantification of serums from normal females 
allowed establish the FBs range levels present in 
normal females. To get good success pregnancy 
in this specie the BFs range must fluctuate in le-
vels highest than 30% in average (borderline). In 
addition, the BFs levels were correlated with the 
numbers of birth thus the more births the higher 
levels of BFs were observe for the average the BFs 
in post-birth females (Mean= 45%). The BFs ave-
rage in nulliparous females was 17%, suggesting 
that the BFs increased during the first 10 days and 
maintained its high levels during the pregnancy.
Moreover, it was demonstrate that BFs not relate 
to classical antibodies, since serum from several 
species used in one MLC with the same origin in-
hibited the positive reaction and cell proliferation 
in all cases. Thus BFs are inter-specific and not in-
specific like has been claimed in other studies.
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